Oak Ridge Investments’s Pacira BioSciences PCRX Stock Holding History

Oak Ridge Investments’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-148,913	Closed	-$6.75M	–	183
2019 Q4	$6.75M	Sell	148,913 -13,410	-8%	-$570K	0.49%	78
2019 Q3	$6.18M	Sell	162,323 -7,603	-4%	-$303K	0.46%	82
2019 Q2	$7.39M	Sell	169,926 -10,694	-6%	-$454K	0.51%	84
2019 Q1	$6.87M	Sell	180,620 -8,663	-5%	-$338K	0.44%	90
2018 Q4	$8.14M	Sell	189,283 -12,525	-6%	-$585K	0.59%	67
2018 Q3	$9.92M	Sell	201,808 -17,412	-8%	-$753K	0.55%	78
2018 Q2	$7.03M	Sell	219,220 -4,648	-2%	-$160K	0.4%	94
2018 Q1	$6.97M	Sell	223,868 -65,019	-23%	-$2.32M	0.39%	93
2017 Q4	$13.2M	Sell	288,887 -70,171	-20%	-$2.78M	0.63%	63
2017 Q3	$13.5M	Sell	359,058 -115,251	-24%	-$4.64M	0.55%	72
2017 Q2	$22.6M	Sell	474,309 -10,229	-2%	-$475K	0.72%	56
2017 Q1	$22.1M	Sell	484,538 -50,386	-9%	-$2.18M	0.74%	50
2016 Q4	$17.3M	Sell	534,924 -187,010	-26%	-$6.24M	0.56%	55
2016 Q3	$24.7M	Sell	721,934 -7,559	-1%	-$296K	0.64%	52
2016 Q2	$24.6M	Sell	729,493 -46,235	-6%	-$2.27M	0.63%	52
2016 Q1	$41.1M	Sell	775,728 -1,683	-0.2%	-$98.4K	1.04%	39
2015 Q4	$59.7M	Sell	777,411 -11,816	-1%	-$669K	1.43%	28
2015 Q3	$32.4M	Buy	789,227 +343,366	+77%	+$21M	0.77%	45
2015 Q2	$31.5M	Buy	+445,861	New	+$35.1M	0.67%	52

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Oak Ridge Investments's PCRX Position: Q1 2020 in Review

Oak Ridge Investments sold out of Pacira BioSciences (PCRX) in Q1 2020, closing a stake of 148,913 shares — an estimated $6.75M sold.

Oak Ridge Investments first reported a position in PCRX in Q2 2015 and held it in 19 quarters. The position peaked at $59.7M in Q4 2015. 226 funds tracked by Wall St. Rank hold PCRX as of Q1 2020.

Oak Ridge Investments reported no remaining Pacira BioSciences position as of Q1 2020 after selling out during the quarter.
Oak Ridge Investments sold 148,913 Pacira BioSciences shares in Q1 2020, an estimated $6.75M.
Oak Ridge Investments first reported a position in Pacira BioSciences in Q2 2015 and held it in 19 quarters.
Oak Ridge Investments's Pacira BioSciences position peaked at $59.7M in Q4 2015.
226 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2020.

Based on Oak Ridge Investments's 13F filing for Q1 2020, filed 13 May 2020.